The Market Cap Is Small, the Idea Is Huge: Can Allogene (ALLO) Make CAR-T as Easy as Ordering a Drug?
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
Compass Therapeutics (CMPX) Has a “Survival Data” Trapdoor — And 2026 Might Be When It Opens
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
Nuvation (NUVB)’s “Quiet Launch” Isn’t Quiet Anymore: The Patient-Start Numbers That Got Biotech Watching
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next
In this article, we will take a look at the Top 10 Cancer Biotech Small-Caps That Could Shock…
The “No Heart Damage” Cancer Drug Angle: Is Moleculin (MBRX)’s Annamycin the Plot Twist in AML?
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
Achieve Life Sciences (ACHV) Has a June 2026 “Make-or-Break” Date—Is This the Smoking Cessation Biotech Everyone’s Early On?
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
Avalo Therapeutics (AVTX)’s Next 5 Minutes of Fame: The HS Data Drop That Could Shock Traders
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
DBV Technologies (DBVT) Didn’t Chase a Fad — It Built a Category: The Peanut Allergy Patch
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
MindMed (MNMD) Stock 101: Why This Psychedelic Biotech Isn’t Playing Small Anymore
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026
In this article, we will take a look at the Top 5 Best Biotech Micro-Caps With Major Clinical…
ADMA Biologics (ADMA): #1 Biotech Stock Pick for February 2026
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at ADMA…
Here’s What Makes Biohaven (BHVN) a Smart Long-Term Buy
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at Biohaven…
Is it a Wise Move to Acquire Compass Therapeutics (CMPX) Shares?
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at Compass…
Is it Still Worthy to Buy ImmunityBio (IBRX) Shares?
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at ImmunityBio…
Is it Still Safe to Invest in Veracyte (VCYT)?
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at Veracyte…
Top 5 Best Biotech Stocks of February 2026
In this article, we will take a look at the Top 5 Best Biotech Stocks of February 2026.…
Is Ginkgo Bioworks (DNA) a Smart Long-Term Pick?
We recently published our article Top 10 Biotech Stocks With the Biggest Price Gains Today. This article examines…